Medtronic plc
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $36.36B | $33.54B | $32.36B | $31.23B | $31.69B | $30.12B | $28.91B | $30.56B |
| Cost of Revenue | $12.72B | $11.63B | $11.22B | $10.72B | $10.15B | $10.48B | $9.42B | $9.16B |
| Gross Profit | $23.64B | $21.91B | $21.15B | $20.51B | $21.54B | $19.63B | $19.49B | $21.40B |
| Gross Margin | 65.0% | 65.3% | 65.3% | 65.7% | 68.0% | 65.2% | 67.4% | 70.0% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $11.78B | $10.85B | $10.74B | $10.42B | $10.29B | $10.15B | $10.11B | $10.42B |
| Operating Income | $6.47B | $5.96B | $5.14B | $5.49B | $5.75B | $4.48B | $4.79B | $6.27B |
| Operating Margin | 17.8% | 17.8% | 15.9% | 17.6% | 18.2% | 14.9% | 16.6% | 20.5% |
| Interest Expense | — | — | $719.0M | $636.0M | $553.0M | $925.0M | $1.09B | $1.44B |
| Pretax Income | $6.14B | $5.63B | $4.84B | $5.36B | $5.52B | $3.90B | $4.06B | $5.20B |
| Income Tax Expense | $1.30B | $936.0M | $1.13B | $1.58B | $456.0M | $265.0M | $-751.0M | $547.0M |
| Net Income | $4.80B | $4.66B | $3.68B | $3.76B | $5.04B | $3.61B | $4.79B | $4.63B |
| Net Margin | 13.2% | 13.9% | 11.4% | 12.0% | 15.9% | 12.0% | 16.6% | 15.2% |
| EPS (Basic) | $3.75 | $3.63 | $2.77 | $2.83 | $3.75 | $2.68 | $3.57 | $3.44 |
| EPS (Diluted) | $3.73 | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $3.54 | $3.41 |
| Shares Outstanding (Basic) | 1.28B | 1.29B | 1.33B | 1.33B | 1.34B | 1.34B | 1.34B | 1.35B |
| Shares Outstanding (Diluted) | 1.29B | 1.29B | 1.33B | 1.33B | 1.35B | 1.35B | 1.35B | 1.36B |
| Dividends Per Share | $2.84 | $2.80 | $2.76 | $2.72 | $2.52 | $2.32 | $2.16 | $2.00 |